Form D — Surebion, Inc.
0002083970-25-000001 · filed Sep 5, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 504(b)(1), other, Rule 506(b)
- Reported offering amount
- $35
- Reported amount sold
- $35
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Surebion, Inc.
- CIK
- 2083970
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 7938 READING AVENUE
LOS ANGELES, California 90045 - Phone
- 3109939664
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Susanne Nichalas · DirectorLos Angeles, California Find on LinkedIn ↗
-
Robert Damoiseaux · DirectorLos Angeles, California Find on LinkedIn ↗
-
Troy Barring · Executive OfficerSanta Clarita, California Find on LinkedIn ↗
-
Stephen Paul Rothman · Executive OfficerMill Valley, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗